AR and Micropenis: Several studies have addressed factors influencing the efficacy of TRT in pediatric patients with micropenis such as mutations in steroid 5α‐reductase type 2 gene (SRD5A2) and androgen receptor (AR), which have been identified as potential causes of poor response to TRT [7, 8].